Figure 4

LDL-cholesterol changes after treatment completion. Forest plot for mean difference (MD) and 95% confidence intervals (CI) for each time-point. DCV/ASV daclatasvir/asunaprevir, SOF/LDV sofosbuvir/ledipasvir, SOF/RBV sofosbuvir + ribavirin, SOF/DCV sofosbuvir + daclatasvir, SVR12 Sustained virological response at 12 weeks, SVR24 Sustained virological response at 24 weeks.